Zinc deficiency dermatoses E60

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 04.02.2024

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Characteristic, eczematous, psoriasiform, often microbially superimposed skin changes in acra and body orifices caused by zinc deficiency of various causes, also involvement of skin appendages (hair, nails).

Etiopathogenesis
This section has been translated automatically.

Different triggers are possible:

Localization
This section has been translated automatically.

acra, centrofacial, anogenital area, in the chronic form also knee, elbow.

Clinical features
This section has been translated automatically.

Acute: episodic papulovesicular, sharply defined eczema. Perioral and perianal erosions, scrotal eczema. Flat blisters in the flexural folds of the fingers and palmae. Delayed wound healing.

Chronic zinc deficiency dermatitis: Eczematous to psoriasiform skin changes, possibly generalized exsiccation eczema, acneiform folliculitis, diffuse alopecia, nail dystrophy, Beau-Reil's transverse furrows of the nails. Other disorders: growth retardation, susceptibility to infections, gastrointestinal disorders, photophobia, mental disorders. See also Acrodermatitis enteropathica.

Diagnosis
This section has been translated automatically.

Reduction of serum zinc levels and alkaline phosphatase.

Differential diagnosis
This section has been translated automatically.

Therapy
This section has been translated automatically.

  • Alimentary intake: 33% of the zinc sources in the diet come from meat and meat products, 25% from milk, dairy products and eggs, 20% from cereal products and 20% from other sources.

    Remember! A high calcium content and a low-fat diet worsen the zinc utilization.

  • Drug substitution: Mostly oral, in severe cases parenteral administration of soluble zinc compounds such as zinc sulphate, zinc acetate, zinc lactate under serum zinc level control. Substitution e.g. with unicinc 20-40 mg/day i.v. or 1-2 Tbl./day p.o. In addition protein substitution (zinc is transported in serum bound to albumin). Serum protein control: Desired plasma protein increase (g/l) times plasma volume (l/kg bw) times 2 = amount of protein substitution required (albumin 5-20%).

Literature
This section has been translated automatically.

  1. Brar BK et al (2003) Acrodermatitis enteropathica-like rash in an exclusively breast fed infant with zinc deficiency. J Dermatol 30: 259-260
  2. Brüske K et al (1987) Zinc and its importance in some dermatological diseases-a statistical analysis. Z Hautkr 62: 125-131
  3. Crone J et al (2002) Acrodermatitis enteropathica-like eruption as the presenting sign of cystic fibrosis--case report and review of the literature. Eur J Pediatr 161: 475-478
  4. Landthaler M et al (1987) Acquired zinc deficiency syndrome. Dermatologist 33: 49-52
  5. Maverakis et al.(2007). Acrodermatitis enteropathica and an overview of zinc metabolism. J Am Acad Dermatol 56: 116-124
  6. Perafan-Riveros C et al (2002) Acrodermatitis enteropathica: case report and review of the literature. Pediatric Dermatol 19: 426-431
  7. Steel M (1988) Zinc deficiency, often not detected - zinc substitution, the therapy of choice. Therapeutic ion 2: 21-27
  8. Weismann K et al (1982) Zinc deficiency dermatoses. Dermatologist 33: 405-410

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 04.02.2024